AstraZeneca to acquire Amolyt Pharma for $1.05B



AstraZeneca plc announced on Thursday that it has entered into a “definitive agreement” to buy Frace-based global biopharmaceutical firm Amolyt Pharma for $1.05 billion in cash. The final tr…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento